Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion in rat liver

Hepatology

Volumn 25, Issue 5, 1997, Pages 1136-1140

  Yamaguchi, Yasuo ^a   Hlsama, Naoya ^a   Okajima, Kenji ^a   Uchiba, Mltsuhiro ^a   Murakami, Kazunori ^a   Takahashi, Yasuo ^b   Yamada, Shinwa ^c   Mori, Katsutaka ^a   Ogawa, Mlchio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b MOCHIDA PHARMACEUTICAL CO   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10A; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; LIVER ENZYME; MYELOPEROXIDASE; THROMBOMODULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LIVER ISCHEMIA; MALE; NEUTROPHIL; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0030916809     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250515     Document Type: Article

References (18)

1. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257:859-864.
2. Esmon NL. Thrombomodulin. Prog Hemost Thromb 1989;9:29-55.
3. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989;264:4743-4746.
4. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987;235:1348-1352.
5. Clouse LH, Comp PC. The regulation of hemostasis: the protein C system. N Engl J Med 1986;314:1298-1304.
6. Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981;68:1221-1228.
7. Gruber A, Harker LA, Hanson SR, Kelly AB, Griffin JH. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Circulation 1991;84:2454-2462.
8. Snow TR, Deal MT, Dickey DT, Esmon CT. Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation 1991; 84:293-299.
9. Esmon CT, Taylor FB, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991;66:160-165.
10. Crawford MH, Grover FL, Kolb WP, McMahan A, O'Rourke RA, McManus LM, Pinckard RN. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988;78:1449-1458.
11. Haerem JW. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronally artery disease. Atherosclerosis 1972;15:199-213.
12. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990;4:3355-3359.
13. Poggetti RS, Moore FA, Moore EE, Bensard DD, Anderson BO, Banerjee A. Liver injury is a reversible neutrophil-mediated event following gut ischemia. Arch Surg 1992;127:175-179.
14. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimeh NF. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 1981;68:714-721.
15. Abe H, Okajima K, Okabe H, Takatsuki K, Binder BR. Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endotheial cells in vitro. J Lab Clin Med 1994;123:874-881.
16. Koga S, Ogawa S, Kuwahara K, Brett J, Leavy JA, Ryan J, Koga Y, et al. Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J Clin Invest 1992;90:1007-1015.
17. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045-1049.
18. Watanabe K, lida M, Takaishi K, Suzuki T, Hamada Y, Iizuka Y, Turufuji S. Chemoattractant for neutrophils in lipopolysaccharide-induced inflammatory exudate from rats are not interleukin-8 counterparts but gro-gene-products/melanoma-growth-stimulating-activity-related factors. Eur J Biochem 1993;214:267-270.